ENFN Stock Overview
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$10.47|
|52 Week High||US$23.21|
|52 Week Low||US$7.80|
|1 Month Change||0.096%|
|3 Month Change||-18.08%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-47.15%|
Recent News & Updates
Enfusion: A Compelling Financial SaaS Company
Enfusion is down over 60% since its IPO last year. The company is aiming to disrupt the legacy investment management market with its revamped purpose-built solution. It has a large addressable market as the global AUM and number of firms are continuing to increase. It is showing strong revenue growth and its current valuation is compelling compared to its peers. I rate the company as a buy.
Estimating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Enfusion, Inc...
|ENFN||US Software||US Market|
Return vs Industry: Insufficient data to determine how ENFN performed against the US Software industry.
Return vs Market: Insufficient data to determine how ENFN performed against the US Market.
|ENFN Average Weekly Movement||11.8%|
|Software Industry Average Movement||10.9%|
|Market Average Movement||8.0%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: ENFN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: ENFN's weekly volatility (12%) has been stable over the past year.
About the Company
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.
Enfusion Fundamentals Summary
|ENFN fundamental statistics|
Is ENFN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ENFN income statement (TTM)|
|Cost of Revenue||US$36.02m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-3.05|
|Net Profit Margin||-164.53%|
How did ENFN perform over the long term?See historical performance and comparison
Is ENFN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ENFN?
Other financial metrics that can be useful for relative valuation.
|What is ENFN's n/a Ratio?|
Price to Sales Ratio vs Peers
How does ENFN's PS Ratio compare to its peers?
|ENFN PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
ALKT Alkami Technology
LAW CS Disco
Price-To-Sales vs Peers: ENFN is good value based on its Price-To-Sales Ratio (5.7x) compared to the peer average (7.2x).
Price to Earnings Ratio vs Industry
How does ENFN's PE Ratio compare vs other companies in the US Software Industry?
Price-To-Sales vs Industry: ENFN is expensive based on its Price-To-Sales Ratio (5.7x) compared to the US Software industry average (4.4x)
Price to Sales Ratio vs Fair Ratio
What is ENFN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||5.7x|
|Fair PS Ratio||7.2x|
Price-To-Sales vs Fair Ratio: ENFN is good value based on its Price-To-Sales Ratio (5.7x) compared to the estimated Fair Price-To-Sales Ratio (7.2x).
Share Price vs Fair Value
What is the Fair Price of ENFN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ENFN ($10.47) is trading above our estimate of fair value ($10.17)
Significantly Below Fair Value: ENFN is trading above our estimate of fair value.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ENFN's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Enfusion forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENFN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ENFN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ENFN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ENFN's revenue (26.7% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: ENFN's revenue (26.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ENFN is forecast to be unprofitable in 3 years.
Discover growth companies
How has Enfusion performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Last years earnings growth
Earnings and Revenue History
Quality Earnings: ENFN is currently unprofitable.
Growing Profit Margin: ENFN is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ENFN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ENFN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ENFN is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (26.8%).
Return on Equity
High ROE: ENFN has a negative Return on Equity (-309.05%), as it is currently unprofitable.
Discover strong past performing companies
How is Enfusion's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: ENFN's short term assets ($86.4M) exceed its short term liabilities ($7.7M).
Long Term Liabilities: ENFN's short term assets ($86.4M) exceed its long term liabilities ($497.0K).
Debt to Equity History and Analysis
Debt Level: ENFN is debt free.
Reducing Debt: ENFN had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ENFN has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ENFN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
What is Enfusion current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ENFN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ENFN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ENFN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ENFN's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ENFN has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Thomas Kim (49 yo)
Mr. Thomas Kim serves as Chief Executive Officer at Enfusion Ltd. LLC since March 2020. He has been the Chief Executive Officer at Enfusion, Inc since March 2020 and Director since 2021.He was Chief Execu...
Experienced Management: ENFN's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Experienced Board: ENFN's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: ENFN only recently listed within the past 12 months.
Enfusion, Inc.'s employee growth, exchange listings and data sources
- Name: Enfusion, Inc.
- Ticker: ENFN
- Exchange: NYSE
- Founded: 2021
- Industry: Application Software
- Sector: Software
- Implied Market Cap: US$1.154b
- Market Cap: US$669.605m
- Shares outstanding: 113.05m
- Website: https://www.enfusion.com
Number of Employees
- Enfusion, Inc.
- 125 South Clark Street
- Suite 750
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/07/01 00:00|
|End of Day Share Price||2022/07/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.